Speciality Medicines Limited

Paradise Moon Fund sold 60,000 shares of Speciality Medicines Limited for ₹1.27 Cr at ₹211.00 apiece in a bulk deal.

A pharmaceutical company engaged in marketing and distribution of speciality finished formulations across India. Incorporated in 2021, the company focuses on niche therapeutic areas and builds its business through strategic partnerships with established pharmaceutical manufacturers. Speciality Medi operates as a specialized distribution and marketing platform serving hospitals, clinics, and retail pharmacies with medicines targeting specific disease segments and patient populations in the Indian pharmaceutical sector.

Launched in 2024 by Naveen Bansal (IIM-Calcutta, 15+ years in MSME) targeting Rs 750 cr over time. Dedicated to anchoring SME IPOs and capturing pre and post-listing gains in India's small business segment. Custodian: Nuvama.